Jul 22 |
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release
|
Jul 18 |
Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
|
Jul 15 |
Is The Options Market Predicting A Spike In BioMarin Pharmaceutical (BMRN) Stock?
|
Jul 12 |
Three US Stocks Estimated To Be Trading Below Their Intrinsic Values In July 2024
|
Jul 9 |
BMO sees BMRN, LEGN, SLN as attractive M&A targets
|
Jul 4 |
Peering Into Biomarin Pharmaceutical's Recent Short Interest
|
Jul 1 |
Here’s Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)
|
Jun 23 |
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate
|
Jun 20 |
Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?
|
Jun 18 |
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
|